Biotechnology Recent News
Dicerna Pharma Has Multiple Pipeline Opportunities, Tough Competition, Analyst Says In Neutral Initiation
Turning Neutral: Morgan Stanley Downgrades Sarepta, Loxo Oncology, Global Blood Therapeutics
William Blair: Bluebird Bio Could See Another 'Blue Ribbon Year' In 2018
BofA: The Biotech Sector Is In A 'Perfect Storm' For M&A
It's A Bad Day For Biotechs
Analyst Sees 243% Upside For Corbus Pharma Following Positive Clinical Data
Endocyte Shares Up More Than 100% In 2 Days, But Analyst Sees Even More Upside Possible
3 Reasons To Like Vertex Pharma Shares
Pro: Biotech Is The Hottest ETF Of 2017 With Plenty Of Upside Ahead
Analyst Makes The Case For Ligand As A 'Core' Holding
3 Things Deutsche Bank Likes About Agilent's Q3, And One Thing To Be Cautious Of
Cramer: Small-Cap Biotechs Are Reserved For Speculative Investors
Cyclacel Pharmaceuticals' 35% Spike: Manipulation Or Something Else?
A Bull Call On A Marquee Healthcare ETF
6 Biotechs Still Awaiting December Catalysts
These Biotechs Are Getting Crushed Following Juno's Cancer Drug Hold
This Biotech ETF Could Be Ready To Party
Here's Why Prima BioMed Is Up 15%
4 Companies Pfizer Just Increased Its Stake In
Shares Of Chimerix Higher By Nearly 6% After Point72 Stake Reveal
Vetr Crowd No Longer Uber-Bearish On Puma Biotech
15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference
Oppenheimer Incrementally More Bullish on Gilead, Remains Cautious On Vertex